These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 15400365)

  • 1. Dihydroxyphenylalanine decarboxylase; preparation and properties of a stable dry powder.
    SCHALES O; SCHALES SS
    Arch Biochem; 1949 Nov; 24(1):83-91. PubMed ID: 15400365
    [No Abstract]   [Full Text] [Related]  

  • 2. Are dihydroxphenylalanine decarboxylase and 5-hydroxytrptophan decarboxylase individual enzymes?
    ROSENGREN E
    Acta Physiol Scand; 1960 Aug; 49():364-9. PubMed ID: 13743456
    [No Abstract]   [Full Text] [Related]  

  • 3. Competitive inhibition of 3, 4-dihydroxyphenylalanine (DOPA) decarboxylase in vitro.
    HARTMAN WJ; AKAWIE RI; CLARK WG
    J Biol Chem; 1955 Oct; 216(2):507-29. PubMed ID: 13271331
    [No Abstract]   [Full Text] [Related]  

  • 4. A rapid method for the determination of dihydroxyphenylalanine decarboxylase in animal tissues.
    DIETRICH LS
    J Biol Chem; 1953 Oct; 204(2):587-91. PubMed ID: 13117832
    [No Abstract]   [Full Text] [Related]  

  • 5. Actions of the decarboxylase inhibitor, alpha-methyl-3,4-dihydroxyphenylalanine, in the dog.
    GOLDBERG LI; DACOSTA FM; OZAKI M
    Nature; 1960 Nov; 188():502-4. PubMed ID: 13706461
    [No Abstract]   [Full Text] [Related]  

  • 6. [CLINICAL EXPERIENCES WITH ALPHA-METHYL-DOPA, A DECARBOXYLASE INHIBITOR].
    RIPKA O
    Cas Lek Cesk; 1965 Feb; 104():173-5. PubMed ID: 14308252
    [No Abstract]   [Full Text] [Related]  

  • 7. Decarboxylase inhibitors as hypotensive agents.
    DELGADO JN; COSGROVE EP
    Tex State J Med; 1963 Jun; 59():529-30. PubMed ID: 14026697
    [No Abstract]   [Full Text] [Related]  

  • 8. [EFFECT OF ALPHA-METHYLDOPALANINE AND SERYLTRIHYDROXYBENZYLHYDRAZINE (RO 4-4602) ON THE DOPA-DECARBOXYLASE ACTIVITY].
    CHRUSCIEL TL; POJDA SM
    Acta Physiol Pol; 1965; 16():111-5. PubMed ID: 14338596
    [No Abstract]   [Full Text] [Related]  

  • 9. Decarboxylase inhibitors in the treatment of hypertension.
    BREST AN; MOYER JH
    Am J Cardiol; 1962 Jan; 9():116-9. PubMed ID: 13872878
    [No Abstract]   [Full Text] [Related]  

  • 10. [ANTIHYPERTENSIVE ACTION OF A DOPA-DECARBOXYLASE INHIBITOR: METHYLDOPA].
    BENZI G
    Farmaco Prat; 1963 Dec; 18():688-93. PubMed ID: 14121022
    [No Abstract]   [Full Text] [Related]  

  • 11. [Inhibition of APO-DOPA-decarboxylase by phosphopyridoxyl-amino acids].
    Borri-Voltattorni C; Minelli A; Turano C
    Boll Soc Ital Biol Sper; 1971 Nov; 47(21):700-2. PubMed ID: 5147578
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of alpha-methyl DOPA and some other decarboxylase inhibitors on brain 5-hydroxtryptamine.
    DRAIN DJ; HORLINGTON M; LAZARE R; POULTER GA
    Life Sci (1962); 1962 Mar; 1():93-7. PubMed ID: 13887715
    [No Abstract]   [Full Text] [Related]  

  • 13. [In-vitro action of L-dopa (3-4 dihydroxyphenylalanine) on cerebral glutamate decarboxylase (GAD) and on -aminobutyric transaminase (GABA-T) in rats].
    Macaione S; Mattaliano G; Livrea P
    Boll Soc Ital Biol Sper; 1972 May; 48(9):216-21. PubMed ID: 5070092
    [No Abstract]   [Full Text] [Related]  

  • 14. [A method for determining aromatic amino acid decarboxylase].
    Streffer C
    Biochim Biophys Acta; 1967 May; 139(1):193-5. PubMed ID: 6033470
    [No Abstract]   [Full Text] [Related]  

  • 15. [ACTION OF 5-HTP/DOPA DECARBOXYLASE INHIBITORS ON DIURESIS, URINARY ELECTROLYTES AND RELEASE OF THE ANTIDIURETIC HORMONE].
    CAHN J; HEROLD M; BARRE N
    C R Seances Soc Biol Fil; 1964; 158():1331-5. PubMed ID: 14210566
    [No Abstract]   [Full Text] [Related]  

  • 16. DISSOCIATION OF THE DECARBOXYLASE-INHIBITING AND NOREPINEPHRINE-DEPLETING EFFECTS OF ALPHA-METHYL-DOPA, ALPHA-ETHYL-DOPA, 4-BROMO-3-HYDROXY-BENZYLOXYAMINE AND RELATED SUBSTANCES.
    LEVINE RJ; SJOERDSMA A
    J Pharmacol Exp Ther; 1964 Oct; 146():42-7. PubMed ID: 14221224
    [No Abstract]   [Full Text] [Related]  

  • 17. [L-dopa therapy of Parkinson's syndrome. Comparison of pure L-dopa and the combination preparation L-dopa and decarboxylase inhibitor].
    Görlich J; Markus E
    Dtsch Med Wochenschr; 1972 Aug; 97(34):1246-8. PubMed ID: 5048316
    [No Abstract]   [Full Text] [Related]  

  • 18. [THE ROLE OF CATECHOLAMINES IN THE CONTROL OF HYPOTHALAMIC NEUROSECRETION. EFFECTS OF RESERPINE, A MONOAMINE OXIDASE INHIBITOR AND DIFFERENT D-1 DOPA 5-HTP DECARBOXYLASE INHIBITORS].
    SOULAIRAC A; SOULAIRAC ML
    Agressologie; 1964; 5():465-71. PubMed ID: 14192332
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of parkinsonism using a combination of L-dopa and decarboxylase inhibitor].
    Völler GW; Muschard F
    Med Welt; 1973 Apr; 24(17):705-7. PubMed ID: 4750934
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of freezing and storage methods on concentrations of brain DOPA and 5 HTP after pretreatment with a decarboxylase inhibitor.
    McNamara MC; Miller AT; Davis JN
    Res Commun Chem Pathol Pharmacol; 1977 Mar; 16(3):569-72. PubMed ID: 300489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.